Journal article Published 2020
Treatment of Allergic Asthma With Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 ( Ormdl3) Expression and Normalizes Ceramide Imbalance
The Journal of Pharmacology and Experimental Therapeutics 373(3), 476-487 (2020)
- 2020 Year
- 32273303 PMID
Cite this publication
YOUSSEF, M., J. DE SANCTIS, J. SHAH, D. DUMUT, M. HAJDÚCH, A. NAUMOVA, D. RADZIOCH: Treatment of Allergic Asthma With Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 ( Ormdl3) Expression and Normalizes Ceramide Imbalance. The Journal of Pharmacology and Experimental Therapeutics. 2020, 373(3), 476-487, ISSN: 0022-3565, PMID: 32273303.
Details
- ISSN
- 0022-3565
